PROCEPT BioRobotics Corporation provided revenue guidance for the full year 2024. The company projected revenue for the full year 2024 to be approximately $210 million, which represents 54% growth over the company's prior year revenue.
PROCEPT BioRobotics Corporation
Equities
PRCT
US74276L1052
Medical Equipment, Supplies & Distribution
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
61.48 USD | +1.43% | +17.94% | +47.12% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+47.12% | 3.12B | |
-3.69% | 184B | |
-1.64% | 107B | |
-1.81% | 67.52B | |
+2.02% | 50.06B | |
+10.04% | 45.67B | |
+3.40% | 41B | |
+3.88% | 26.73B | |
+4.13% | 26.47B | |
+15.23% | 25.05B |
- Stock Market
- Equities
- PRCT Stock
- News PROCEPT BioRobotics Corporation
- PROCEPT BioRobotics Corporation Provides Revenue Guidance for the Full Year 2024